×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
18 Jul 2024
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the launch of a new sprinkle formulation of
...
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
In the IDeate-Lung01 Phase 2 trial, Ifinatamab Deruxtecan demonstrated clinically meaningful response rates in patients with extensive-stage small cell lung cancer
With Fifth NovaSeq X Plus System in Europe, Novogene Europe Expands Sequencing Capabilities
Dr. Zivjena Vucetic Appointed as Chief Medical Officer at Mission Bio to Lead Biopharma Partnerships and Clinical Adoption
European Commission Approves DAYBU® (Trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms Associated with Rett Syndrome in the European Union
By
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc.
24 Aug 2026
Upsher-Smith Expands Neurology Portfolio with the Launch of Glatiramer Acetate Injection
By
Upsher-Smith Laboratories, LLC
Upsher-Smith Laboratories, LLC
21 Aug 2026
Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma
By
Dunbar Pharmaceuticals
Dunbar Pharmaceuticals
18 Aug 2026
Former DePuy Synthes U.S. President Joins Peptilogics Board
By
Peptilogics
Peptilogics
18 Aug 2026
PanTRKare™ Is Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
By
Jiangsu Vcare Pharmatech Co., Ltd.
Jiangsu Vcare Pharmatech Co., Ltd.
17 Aug 2026
Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories
By
Bruker Corporation
Bruker Corporation
11 Aug 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe
By
Galderma
Jul 30
Avenacy Enters U.S. Market with Launch of Doxycycline for Injection, USP
By
Avenacy
May 27
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research
By
Thermo Fisher Scientific Inc
Jun 03
August
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
